Home›Stock Screener›Natco Pharma›Quarterly Results

Natco Pharma Quarterly Results

Latest Quarter Net Profit
₹203 Cr
QSept 2026
Quarterly Results

Natco Pharma quarterly results. In Sept 2026, Natco Pharma (NATCOPHARM) reported revenue ₹1,019 Cr and net profit ₹203 Cr — revenue -30.3% YoY. Also explore Natco Pharma share price performance to track price trends across different timeframes.

NATCOPHARM Quarterly Results — Revenue, Profit & EPS Highlights

Natco Pharma latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. View NATCOPHARM yearly price range for the annual high/low range and current price position.

  • Revenue of ₹1,019 Cr in Sept 2026 (+24.7% vs Mar 2026, -30.3% vs Sept 2025)
  • Net Profit of ₹203 Cr in Sept 2026 (-24.5% vs Mar 2026, -60.8% vs Sept 2025)
  • EBITDA of ₹310 Cr in Sept 2026 (+51.2% vs Mar 2026)
  • Operating Margin of 27.0% in Sept 2026 (+10.0pp vs Mar 2026)
  • Earnings Per Share of ₹11.31 in Sept 2026 (-24.4% vs Mar 2026)

Natco Pharma Quarterly Results — Revenue, EBITDA, Net Profit & EPS

NATCOPHARM quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Sept 2026 Mar 2026 Jun 2026 Sept 2025 Mar 2025 QoQ YoY
Revenue (₹ Cr) 1,019 817 794 1,463 1,287 24.7% -30.3%
Net Profit (₹ Cr) 203 269 207 518 406 - -
EBITDA (₹ Cr) 310 205 246 679 614 - -
EPS (₹) 11.31 14.96 11.53 28.94 22.70 - -
Operating Margin (%) 27.0% 17.0% 25.0% 42.0% 45.0% - -

NATCOPHARM Share Price Trend — 1-Year Movement Across Quarterly Results

Natco Pharma 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. For annual financials, live price and key ratios, visit Natco Pharma screener.

Profitability Ratios

Profit Margin 19.9%
EBITDA Margin 30.4%
Operating Margin 27.0%
ROE (Annual) 8.8%

Balance Sheet Highlights

Total Assets ₹11,074 Cr
Total Equity ₹9,221 Cr
Current Assets ₹ Cr
Current Liabilities ₹172 Cr

Cash Flow Analysis

Operating Cash Flow ₹1,768 Cr
Investing Cash Flow ₹-1,987 Cr
Financing Cash Flow ₹298 Cr
Net Cash Flow ₹79 Cr

Current Market Data

Current Price ₹821.95
Exchange NSE
Last Updated Nov 19, 2026

NATCOPHARM vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

Natco Pharma latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2026
₹451,074.97 Cr 1900.0 16,617 1,995 +10.6% - 12.0% 228.9
Divis Laboratories
Sept 2026
₹294,139.19 Cr 11178.0 3,770 1,127 +26.3% - 29.9% 263.1
Torrent Pharmaceuti…
Mar 2026
₹188,719.51 Cr 4611.0 4,111 364 +27.7% +42.2% 8.9% 400.6
Apollo Hospitals
Sept 2026
₹126,832.45 Cr 8738.0 7,673 660 +15.2% - 8.6% 199.4
Laurus Labs
Sept 2026
₹125,946.78 Cr 2306.0 2,219 436 +21.7% - 19.6% 282.3
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data

QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores